Analysts Set Avidity Biosciences, Inc. (NASDAQ:RNA) PT at $65.80
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have covered the stock in the last […]
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have covered the stock in the last […]
